| Autor: |
Valeriano, Alline Teixeira, Camara, Lais Santos, Bernardes, Vanessa de Fátima, Pais, Fabiano Sviatopolk‐Mirsky, Araújo, Flávio Marcos Gomes, Salim, Anna Christina de Matos, Fernandes, Gabriel da Rocha, Stussi, Fernanda, Gomes, Carolina Cavalieri, de Andrade Santos, Pedro Paulo, de Souza, Lélia Batista, Gomez, Ricardo Santiago, Diniz, Marina Gonçalves |
| Předmět: |
|
| Zdroj: |
Journal of Oral Pathology & Medicine; Oct2024, Vol. 53 Issue 9, p577-583, 7p |
| Abstrakt: |
Background: Ameloblastoma is a locally destructive benign odontogenic tumor. While the neoplastic cells of conventional ameloblastoma can infiltrate the connective tissue and bone, in unicystic ameloblastoma the epithelium is encapsulated. The mechanisms driving ameloblastoma's bone resorption remains unclear. Methods: RNA sequencing (RNA‐seq) was performed in a discovery cohort of conventional ameloblastoma, and pathway enrichment analysis was carried out. mRNA levels of MMP13, a gene associated with bone resorption, were assessed using RT‐qPCR in a larger cohort of conventional ameloblastoma and in unicystic ameloblastoma. Zymogram gels and the immunoexpression profile of collagenase 3 (encoded by MMP13 gene) were evaluated as well. Results: Enriched pathways related to bone mineralization and upregulation of MMP13 were observed in ameloblastomas. Collagenolytic activity of collagenase 3 was detected in the tumor lysates. Collagenase 3 immunopositivity was observed in ameloblastomatous epithelium infiltrating the fibrous capsule of unicystic ameloblastoma. At the tumor–bone interface, collagenase 3 expression was detected in stromal cells, osteoblasts, and osteocytes. Conclusion: The results indicate a potential involvement of MMP13 in ameloblastoma‐related bone resorption and progression. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text